COVID-19感染またはワクチン接種に関連したロザセア悪化の危険因子の調査:横断的な研究
Xidie Yin1, Yiting Zhao1, Liyuan Zhou1
1Institute of Photomedicine, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, China.
Acta dermato-venereologica
|September 5, 2025
まとめ
低体量指数 (BMI) は,COVID-19のワクチン接種または感染後にロザセアの発作を増加させる. 灼熱性,刺痛性,非パプルポスチュラ性ロザセアサブタイプは,ワクチン接種後の悪化リスクが高い.
科学分野:
- 皮膚科
- 感染症
- 免疫学
背景:
- COVID-19 (新型コロナウイルス感染症 2019) は,様々な皮膚学的症状と関連付けられています.
- COVID-19感染とワクチン接種後にロザケアの発作が報告されています.
研究 の 目的:
- COVID-19 発症後の発症した患者と発症しなかった患者を比較する
- COVID-19 感染症またはワクチン接種後のロザセアの悪化に寄与する危険因子を特定する.
主な方法:
- カスタマイズされた電子アンケートでは,104人のロザセア患者のCOVID-19の状況,人口統計,およびロザセアの特徴に関するデータを収集した.
- 参加者は,COVID-19後のロザセアの悪化に基づいて分類された.
- 多変数ロジスティック回帰分析は,リスク要因を特定するために使用されました.
主要な成果:
- ワクチン接種後,15. 4%の患者で,感染後28. 8%の患者で,ロザセアが悪化した.
- 併発性疾患 (代謝性,アレルギー性疾患) は著しく悪化するリスク (OR=11. 083) を増加させた.
- 低BMIは,ワクチン接種後の悪化リスクと感染リスクの上昇と関連していた (OR=0. 646とOR=0. 731).
- 燃える/刺さる症状 (OR=8. 978) と非パプルポスチュール性赤毛症は,ワクチン接種後の悪化リスクが高く予測された.
- 感染後の発症リスクが増加した (OR=8. 288).
結論:
- 低BMIは,COVID-19のワクチン接種または感染後のロザセアの悪化の危険因子です.
- 灼熱や刺痛などの特定の症状と,特定のローザセアのサブタイプは,ワクチン接種後の悪化リスクの増加と関連しています.
さらに関連する動画
関連する概念動画
Factors Affecting the Risk of Infection
12.2K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
12.2K
Psychoneuroimmunology: Cardiovascular Disease
77
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
77
Asthma-I: Introduction
2.8K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
Myocarditis III: Medical Management
15
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
15
Vaccinations
45.3K
Overview
45.3K
Coronary Artery Disease I: Introduction
54
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
54


